Merit Medical Systems, Inc. (MMSI)

NASDAQ: MMSI · IEX Real-Time Price · USD
52.94
-0.54 (-1.01%)
At close: Jun 24, 2022 4:00 PM
50.30
-2.64 (-4.99%)
After-hours: Jun 24, 2022 5:01 PM EDT
-1.01%
Market Cap 3.00B
Revenue (ttm) 1.10B
Net Income (ttm) 48.04M
Shares Out 56.68M
EPS (ttm) 0.83
PE Ratio 63.78
Forward PE 21.01
Dividend n/a
Ex-Dividend Date n/a
Volume 724,718
Open 53.86
Previous Close 53.48
Day's Range 52.76 - 55.35
52-Week Range 51.31 - 73.85
Beta 1.02
Analysts Buy
Price Target 77.52 (+46.4%)
Earnings Date Aug 4, 2022

About MMSI

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid man... [Read more...]

Industry Health Care Equipment & Supplies
IPO Date Aug 9, 1990
CEO Fred Lampropoulos
Employees 6,500
Stock Exchange NASDAQ
Ticker Symbol MMSI
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 14 analysts, the average rating for MMSI stock is "Buy." The 12-month stock price forecast is 77.52, which is an increase of 46.43% from the latest price.

Price Target
$77.52
(46.43% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Here's Why Merit Medical (MMSI) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Here's Why You Should Retain Merit Medical (MMSI) Stock Now

Investors continue to be optimistic about Merit Medical (MMSI) due to its strong product portfolio.

Why Is Merit Medical (MMSI) Down 4.3% Since Last Earnings Report?

Merit Medical (MMSI) reported earnings 30 days ago. What's next for the stock?

Merit Medical (MMSI) is a Top-Ranked Value Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Merit Medical Systems, Inc.

Wilmington, Delaware--(Newsfile Corp. - May 9, 2022) - Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of Merit Medical Systems, Inc. (NasdaqGS: MMSI) on behalf ...

Merit Medical (MMSI) Q1 Earnings Beat, FY22 View Unchanged

Merit Medical (MMSI), in the first quarter, benefits from revenue growth in both its segments and from all of the product categories within its Cardiovascular unit.

Merit Medical (MMSI) Q1 Earnings and Revenues Top Estimates

Merit Medical (MMSI) delivered earnings and revenue surprises of 12.77% and 4.54%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Merit Medical Reports Results for Quarter Ended March 31, 2022

*  Constant currency revenue; constant currency revenue, organic; non-GAAP EPS; non-GAAP net income; non-GAAP operating income and margin; non-GAAP gross margin; and free cash flow are non-GAAP financia...

Merit Medical Announces Chief Operating Officer Transition

Ronald A. Frost to Retire After More than 30 Years of Service Neil Peterson, a 27-Year Company Veteran, Appointed COO

Merit Medical's Chief Legal Officer and Corporate Secretary, Brian Lloyd, Receives Corporate Counsel Award from Utah ...

SOUTH JORDAN, Utah, April 21, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, is proud to announce that Brian G....

Merit Medical (MMSI) Expected to Beat Earnings Estimates: Should You Buy?

Merit Medical (MMSI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Merit Medical's (MMSI) Latest Launch to Boost Patient Outcome

Merit Medical's (MMSI) latest well-designed tray is expected to simplify the thoracostomy procedure and reduce treatment time, especially in critical situations.

Merit Medical Announces Launch of ReSolve® Thoracostomy Tray

Intuitive design facilitates procedural efficiency, supports minimally invasive patient care Intuitive design facilitates procedural efficiency, supports minimally invasive patient care

Merit Medical Systems to Announce First Quarter Results on April 27, 2022

SOUTH JORDAN, Utah, April 13, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnosti...

Merit Medical's (MMSI) SCOUT Bx Delivery System Gets FDA Nod

Merit Medical's (MMSI) receipt of FDA clearance for the SCOUT Bx system can streamline treatment for cancer patients.

Merit Medical Receives FDA Clearance for SCOUT Bx™ Delivery System

New technology is designed to allow physicians to place SCOUT® reflector at time of biopsy for breast localization under stereotactic and MRI guidance New technology is designed to allow physicians to p...

Here's Why You Should Retain Merit Medical (MMSI) Stock For Now

Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.

Merit Medical's (MMSI) Product Included in FDA's Program

Receipt of the Breakthrough Device Designation for Merit Medical's (MMSI) Embosphere Microspheres is expected to improve patient outcome.

Merit Medical Receives FDA “Breakthrough Device Designation” for Embosphere® Microspheres for Use in Genicular Artery...

SOUTH JORDAN, Utah, March 07, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), announced today that it has received “breakthrough device designation” from the U.S. Food & Drug Admini...

Merit Medical's (MMSI) Q4 Earnings, Revenues Top Estimates

Merit Medical (MMSI), in the fourth quarter, benefits from revenue growth in both its segments, and from majority of the product categories within its Cardiovascular unit.

Merit Medical (MMSI) Beats Q4 Earnings and Revenue Estimates

Merit Medical (MMSI) delivered earnings and revenue surprises of 42% and 3.17%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2021, Issues FY 2022 Guidance

*  Constant currency revenue; constant currency revenue, organic; core revenue; non-GAAP EPS; non-GAAP net income; non-GAAP operating income and margin; non-GAAP gross margin; and free cash flow are non...

Earnings Preview: Merit Medical (MMSI) Q4 Earnings Expected to Decline

Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Domino's, Bath & Body Works, among stocks that are oversold, says Chris Senyek

Chris Senyek, Wolfe Research chief investment strategist, joins 'Power Lunch' to discuss which stocks have been oversold and those investors should watch.

Other symbols: BBWIDPZ

Merit Medical Systems to Announce Fourth Quarter and Year End 2021 Results on February 24, 2022

SOUTH JORDAN, Utah, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic...